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The  identification of transglutaminase  in  the 
growth-factor-dependent mouse mast cell line PTl8 
was accomplished  through its characteristic catalytic 
properties (specificity, calcium  dependency,  and inhi- 
bition  by  iodoacetamide);  and  by  both  immunoprecipi- 
tation  and  Western  blot analysis using affinity purified 
antibody. The enzymatic activity in these cells in- 
creased in association with the release of histamine 
from  the cells induced  by  an  IgE-dependent  mechanism 
or by exposure  to  the  ionophores A23187 or Br-x537A. 
The  increase  in  transglutaminase activity was paral- 
leled  by  a  marked  increase in the level of  protein-bound 
y-glutamylhistamine,  determined  in  radiolabeled  form 
in mast cells that were either metabolically labeled 
with [3H]histidine  or  incubated with [3H]histamine  be- 
fore  degranulation.  The  highest level of  bound y-glu- 
tamylhistamine was found  in  the  immunologically 
stimulated cells. Enzymatic activity and  the  y-glutamyl 
derivative were associated primarily with the cells, 
both before and after stimulation. Separation of 7- 
glutamylhistamine in a proteolytic digest of these cells 
was carried  out  using  a  combination  of  ion  exchange 
chromatography and high performance liquid chro- 
matography.  The  y-glutamyl  compound was identified 
and  quantitated  through  the  enzymatic  production of 
histamine with the  use  of  y-glutamylamine  cyclotrans- 
ferase, an enzyme specific for the disassembly of y- 
glutamylamines. 
The transglutaminases catalyze a calcium-dependent acyl- 
transfer reaction between peptide-bound glutamine residues 
and primary amines including the €-amino group of lysine 
residues in appropriate peptides. The production of e(y- 
glutamy1)lysine bonds between proteins is perhaps the most 
important in  vivo function of the transglutaminases.  Promi- 
nent examples include the covalent polymerization of fibrin, 
the formation of a vaginal plug postejaculation in rodents, 
and  the production of a cornified envelope during  terminal 
differentiation of keratinocytes (for reviews, see Folk and 
Finlayson, 1977; Folk, 1980; Thacher  and Rice, 1985). 
Although it has long been recognized (Clarke et al., 1959) 
that a variety of primary  amines  can serve as  substrates  for 
transglutaminases, this was considered to be an in  vitro phe- 
nomenon. Interest  in  this  area, however, led to  the develop- 
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ment of sensitive assay systems for transglutaminases (Lor- 
and and Ong, 1966; Pincus and Waelsch, 1968; Folk and 
Chung, 1973; Gross et al., 1977). Recent studies have provided 
evidence for a possible physiological substrate function for 
primary amines, namely the polyamines prevalent in cells and 
body  fluids. y-Glutamyl derivatives of polyamines have been 
identified in proteolytic digests of mitogen-stimulated lym- 
phocytes and clotted seminal plasma (Folk et al., 1980). In 
addition, indirect evidence for covalent polyamine-protein 
conjugates in human plasma (Seale et al., 1977), amniotic 
fluid (Chan et al., 1979), and fibroblasts (Fan et aL, 1983) has 
been reported. 
Histamine  is of recognized  biological importance and occurs 
in significant concentrations  in  tissues  and body fluids 
(Beaven, 1982). The possible in vivo occurrence of protein- 
histamine conjugates, formed by transglutaminase  action, was 
suggested by early investigators (Ginsburg et aL, 1963)  who 
found significant amounts of histamine associated with pro- 
teins in the liver of mice which had been injected with 
histamine  and endotoxin. In this paper we report the concom- 
itant increase in  transglutaminase activity and formation of 
protein-bound y-glutamylhistamine in degranulating mouse 
mast cells activated by both immunologic and nonimmuno- 
logic stimuli. The concept that these two events  are cause and 
effect related is thus given substantial support. 
EXPERIMENTAL PROCEDURES 
Materiak-Br-x537A (provided by Dr. W. E. Scott, Hoffman-La 
Roche Inc., Nutley, NJ), A23187 (Calbiochem-Behring), Carboxypep- 
tidase A, B, and Y (Sigma), Pronase and aminopeptidase M (Boeh- 
ringer Mannheim),  Protein A-Sepharose-4B (Pharmacia  Fine Chem- 
icals), and prestained molecular weight standards (Bethesda Research 
Laboratories) were obtained from the sources indicated. [ring 2,side 
~huin-3-~H]Histidine (12.8 Cilmmol), [ring meth~lenes-~HJhista- 
mine.2HCl (52 Ci/mmol), and [4,5-3H]leucine (52.9 Ci/mmol) were 
purchased from New England Nuclear. Succinylated &casein and 
guinea pig liver transglutaminase were the gifts of Dr. S. I. Chung 
(National Institute of Dental Research, National Institutes of Health, 
Bethesda, MD). y-Glutamylamine cyclotransferase was purified by 
the published procedure (Fink and Folk, 1983) and was of purity 
similar to that reported. Rabbit anti-transglutaminase antibodies 
were prepared by immunization of rabbits with purified human red 
blood cell transglutaminase. The anti-transglutaminase antibodies 
were purified from the globulin fraction of the immune serum by 
affinity chromatography on a column of guinea pig liver transgluta- 
minase immobilized on cyanogen bromide-activated Sepharose. De- 
tails of the preparation, purification, and characterization of these 
antibodies are described elsewhere (Fesus and Arato, 1985). 
Growth and Muinternnee of PPI8 Cells-The PT18 cell line was 
obtained as a subline of a parent murine cell line that was isolated 
from antigenically stimulated spleen cells (Pluznik  et al., 1982). The 
cells were cultured at 37 “C in a humidified atmosphere of 5% COz, 
95% air,  in RPMI 1640  medium (DUTCH modification, Flow Labo- 
ratories, McLean, VA) to which had been added L-glutamine (4 mM), 
2-mercaptoethanol (50 pM),  penicillin (50 units/ml), streptomycin 
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(50 mg/ml), nonessential amino acids (100 PM each acid), and sodium 
pyruvate (1 mM) (P cell medium). The medium was also supplemented 
with heat-inactivated fetal calf serum (10%) and the supernatant 
from concanavalin A (ConA')-stimulated mouse splenocytes (50%) 
prepared essentially according to  the method of Schrader and Clark- 
Lewis (1981). The cells were routinely passaged at 4- to 5-day inter- 
vals by halving the culture and adding 10 ml of fresh medium which 
was supplemented as described above. In some experiments the cells 
were  grown for 4 days at a starting density of -0.5 X lo6 cells/ml in 
media containing 5 pCi/ml of [3H] histidine or 5 pCi/ml of radioactive 
histidine and 50 pCi/ml of r3H]leucine. 
Stimulation of Cells  to Release Histamine-The cells were recovered 
from the cultures by centrifugation (10 min, 4 "C, 400 X g), washed, 
and resuspended in a modified HEPES-buffered Tyrode's solution, 
pH 7.4 (Barrett et el., 1983). For experiments involving an immuno- 
logic stimulus, 2-4 X lo6 cells/ml were then passively sensitized with 
hybridoma-derived mouse anti-ovalbumin IgE (a gift from Dr. R. P. 
tutes of Health,  Bethesda, MD) 1:500 dilution for 1 h at 37 "C with 
Siraganian, National Institute of Dental Research, National Insti- 
gentle agitation. The cells were next washed twice in the  HEPES- 
buffered Tyrode's solution to remove unbound antibody. The release 
experiments were carried out a t  37 "C according to  the method of 
Atkinson et al. (1979) using -1-2 X lo6 cells/reaction tube in a 
volume of 1 ml. (In  the experiments when proteolytic digestion of 
cellular proteins followed stimulation, the number of cells was in- 
creased to 4-6 X 107/tube in 2 ml). Passively sensitized cells were 
challenged with aggregated ovalbumin (10 hg/ml). Experiments  in- 
volving nonimmunologic secretagogues (ionophore A23187, 1.0 pM; 
ionophore Br-x537A, 10 p ~ ;  and ConA, 10 pg/ml) utilized cells which 
had been washed but not'passively sensitized. Release was terminated 
at  10 min by the addition of an equal volume of ice-cold buffer or 
20% trichloroacetic acid (the  latter was used in the digestion experi- 
ments). The cells were immediately separated from the released 
histamine  in the  supernatant by centrifugation and boiled (10 min) 
in fresh Tyrode's buffer to release residual histamine. Histamine in 
the cellular and  supernatant fractions was assayed fluorimetrically 
(Shore et aL, 1959), either manually or using a commercial autoana- 
lyzer (Alpkem, Clackamas, OR). 
Assay of Transglutaminase Actiuity-After incubation and stimu- 
pended in 300 pl of TBS (Tris-buffered saline:20 mM Tris-HC1, 150 
lation to degranulate, -1-2 X lo7 PT18 cells were centrifuged, SUS- 
mM NaCl, 1 mM EDTA, pH 7.6), and disrupted by quickly freezing 
and thawing three times. Portions of the cell extract (100-200 pg of 
protein) were incubated at  37 "C  in a total volume of 200 pl of TBS 
containing 1 mM dithiothreitol, 4 mg of succinylated @-casein, 5 mM 
CaCl, 2 mM histamine (in excess of the amount  contributed by the 
cells), 0.5 p~ [3H]histamine, and 0.1 FM aminoguanidine (to inhibit 
histaminase) at pH 7.6. At 3- and 13-min intervals 80-pl aliquots 
were made 10% in trichloroacetic acid and the precipitates were 
exhaustively washed with 5% trichloroacetic acid on GF/A Whatman 
filters, The protein-bound radioactivity was determined in Hydrofluor 
counting liquid (National Diagnostics, Somerville, NJ) by liquid 
scintillation spectrometry. The activity values were corrected for 
histamine provided by the  mast cells in  the assay mixture. A K,,, of 
2.2 X M was estimated in a separate experiment in which 
histamine level  was varied. The protein  concentration  in cell extracts 
was determined according to Bradford (1976) using bovine y-globulin 
as standard. 
Proteolytic Digestion of Cellular Proteins-Washed and centrifuged 
PT18 cells (6 X lo7) were suspended in 400 pl of cold TBS and 
quickly frozen and thawed three times. An equal volume of 20% 
trichloroacetic acid was added and  the mixture was sonicated and 
centrifuged at 9500 X g for 2 min. The precipitate was washed three 
times with 1.5-ml portions of 5% trichloroacetic acid and  three times 
with 1.5-ml portions of ether. The residual ether was allowed to 
evaporate and  the resulting  precipitate was suspended in 0.2 ml  of 
0.2 M N-ethyl morpholine acetate buffer (pH 8.1). Protein digestion 
was carried out by sequential addition of proteolytic enzymes directly 
to  the reaction mixture a t  37 "C in the presence of 0.02% sodium 
azide as follows: Pronase, 5 mg/ml, for 18 h; a second Pronase 
addition, 5 mg/ml, 18 h; 1 mg/ml aminopeptidase M for 65 h; 0.6 mg/ 
ml carboxypeptidase A; 0.4 mg/ml carboxypeptidase B; and 0.4 mg/ 
ml carboxypeptidase Y for 24 h. Before each addition of enzyme the 
" 
The abbreviations used are: ConA, concanavalin A; HEPES, N- 
2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid; SDS, sodium do- 
decyl sulfate; ELISA, enzyme-linked immunosorbent assay. 
sample was boiled for 5 min to destroy proteases added previously. 
Finally, a volume of 10% trichloroacetic acid equal to  that of the final 
digest was added and  the precipitate was  removed by centrifugation. 
The  supernatant was extracted three times with 1.5 ml of ether and 
the aqueous layer was concentrated to a volume suitable for analysis. 
Preparation of Glutemylhistunine-L-y-Glutamylhistamine was 
prepared through  in vitro transglutaminase-catalyzed incorporation 
of histamine in place of ammonia at the carboxamide group of 
benzyloxycarbonyl(2)-L-glutaminyl-L-leucine. The procedure was 
carried out essentially as outlined for the preparation of y-glutamyl- 
polyamines (Folk, 1983), except with the use of histamine as amine 
substrate. High performance liquid chromatographic retention  times 
(minutes) and mobile phase conditions (methanol, 10 mM NH4HC03, 
v/v). respectively, were as follows: 2-Gln-Leu, 3.8, 35/65; histamine 
3.4, 35/65; 2-Glu-Leu 6.7, 35/65 and 13.1, 20/80; 2-Glu 5.4, 20/80; 
rhistamine 
Glu 1.4, 20/80. The carboxyl-terminal L-leucine was removed by the 
use of the enzyme Carboxypeptidase A. Removal of the benzyloxycar- 
bony1 group was accomplished by treating  the dried intermediate with 
a small  amount of 30% hydrogen bromide in acetic acid. After 30 min 
at room temperature the acids were removed under vacuum over 
KOH, and  the resulting  y-glutamylhistamine was dissolved in water 
and stored at -30 "C. Histamine used for the synthesis was a mixture 
of labeled and unlabeled material; the y-glutamylhistamine had a 
final specific activity of 5.2 Ci/mol. It chromatographed as a single 
component in  the ion exchange chromatography system described in 
the legend of Fig. 3. 
The covalent succinylated P-casein-histamine conjugate was pre- 
pared enzymatically with the use of guinea pig liver transglutaminase. 
The reaction mixture was identical to  that employed for the assay of 
transglutaminase activity except that cell extracts were replaced by 
a solution of purified enzyme. The reaction was stopped by EDTA 
(5 mM) and  the modified protein conjugates were transferred  into 0.2 
M N-ethylmorpholine acetate buffer (pH 8.1) using a G-25 Sephadex 
column. 
rhistamine  rhistamine 
RESULTS 
In order to explore the possibility that histamine serves as 
a transglutaminase substrate in normal cells in culture, we 
chose for study a pure cell population that contains large 
amounts of histamine  and we examined the relationship be- 
tween the transglutaminase levels and  the histamine cova- 
lently  attached to protein  through amide linkage at  the y- 
carboxyl group of glutamic acid residues. 
Transglutaminuse in PT18 Mouse Mast Cells-The cell 
population employed here is a recently described mouse  cell 
line, PT18, derived from spleen (Pluznik et al., 1982). This 
cell line requires growth factors for proliferation, contains 
histamine (-1 pg/cell), expresses Fc receptors, and  has been 
shown to rapidly release histamine  in response to immuno- 
logic as well as nonimmunologic stimuli  (Barrett et ul., 1984). 
Using monospecific anti-transglutaminase antibody, a pro- 
tein similar in molecular weight to guinea pig liver transglu- 
taminase could be immunoprecipitated from metabolically 
labeled PT18 cells (Fig. lA, lane 2) .  Addition of an excess 
amount of guinea pig transglutaminase to  the cell extract 
neutralized the anti-transglutaminase antibody (Fig. 1A, lane 
3) .  Western blot analysis of the PT18 cell extract following 
SDS-polyacrylamide gel electrophoresis revealed a single 
band of immunoreactive material of apparent molecular 
weight 77,000 (Fig. 1B). The antibody showed a strong  and 
specific reaction with the transglutaminases of guinea pig 
liver (apparent M, = 80,000), Chinese hamster ovary cells 
(apparent M, = 80,000), and  human red blood cells (apparent 
M, = 92,000). The heterogeneous pattern of species differ- 
ences for migration of the enzyme in SDS gels is in agreement 
with that reported previously (Murtaugh et uL, 1983a). 
The level of transglutaminase  protein  in PT18 cell extracts, 
measured by means of a recently developed ELISA technique 
(Fesus and Arato, 1985), was found to be 55 +- 14 (mean f 
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TABLE I 
FIG. 1. Detection of tissue transglutaminase in mouse mast 
cells by immunoprecipitation (A) and Western blot analysis 
(B) .  A, cells (4-6 X lo6) metabolically labeled with [3H]histidine and 
[3H]leucine were washed twice in 10 ml  of a buffer containing 20 mM 
Tris-HC1, 150 mM NaC1, 1 mM EDTA (pH 7.5) (TBS), suspended in 
3 ml of 50 mM Tris-HC1 (pH 7.6) with 10 mM NaCl, 10 mM benza- 
midine HCl, 0.1% SDS, and 0.05% Tween (lysing buffer) and soni- 
cated. One-ml aliquots of the cell extracts were incubated and gently 
agitated for 5 h a t  23 “C in the presence of Protein A-Sepharose 4B 
(20 pl of the gel slurry) and 5 pg  of either preimmune IgG (lane I), 
affinity purified anti-transglutaminase antibody (lane 2), or anti- 
transglutaminase antibody that had been neutralized by preincuba- 
tion with a 4-fold (by weight) excess of iodoacetamide-inactivated 
guinea pig liver transglutaminase (lane 3) .  The Protein A-immune 
complex precipitates were centrifuged at  1000 X g for 5 min, washed 
3  times with 10 ml of lysing buffer, and processed for SDS-polyacryl- 
amide gel electrophoresis (Laemmli, 1970) on 7.5% discontinuous 
slab gels. Radioactive bands were located by fluorography on Kodak 
X-OMAT AR film. B, the Western  blot procedure was employed to 
detect unlabeled tissue transglutaminase  in  extracts. PT18 cells (2 X 
lo7 in TBS) were lysed by sonication and directly denatured  in sample 
buffer for electrophoresis. After fractionation by SDS electrophoresis 
the proteins were electroblotted onto nitrocellulose (Hawkes et al., 
1982) and visualized using the Bio-Rad Immun-blot (GAR-HRP) 
assay kit. Affinity purified anti-transglutaminase antibody was  used 
at  a concentration of 2 pg/ml. Lane I, human red blood  cell transglu- 
taminase (5 ng); lane 2, the prestained molecular weight standards, 
myosin heavy chain, phosphorylase b, bovine serum albumin, chy- 
motrypsin, lactoglobulin, respectively (molecular weights are given in 
kilodaltons; lanes 3 and 7, Chinese hamster ovary cell extract (50 pg 
of protein); lane 4, cell extract (100 pg) prepared from PT18 cells 
grown in the presence of 1 mM sodium butyrate for four days; lane 5, 
PT18 cell extract (100 pg); lane 6, PT18 cell extract (100  pg) immu- 
noprecipitated by anti-transglutaminase antibody before electropho- 
resis; lane 8, purified guinea pig liver transglutaminase (50 ng). 
S.E., n = 4) ng/mg cell protein based on the use of the guinea 
pig liver enzyme as a  standard. The level of enzyme protein 
(77 k 12 ng/mg protein) found after growth of the PT18 cells 
for 5 days in  the presence of sodium butyrate was not signif- 
icantly  different,  although sodium butyrate is known to  stim- 
ulate transglutaminase  synthesis  in  fibroblasts (Birckbichler 
et al., 1983) and  to  act  as  an  initiator of certain  maturation 
processes of mouse mast cell clones (Galli et al., 1983). 
Characteristic  features of the transglutaminase  reaction, as 
determined by measurement of the incorporation of histamine 
into succinylated casein, were observed with the PT18 cell 
extract (Table I). The activity was calcium-dependent and 
Incorporation of PHJhktamine  into succinylated @-casein  by an 
extract of mouse  mast cells 
























a The assay conditions were as given under “Experimental Proce- 
dures’’ with the exception that in experimental condition I the CaClz 
level  was varied. 
Extract was preincubated with 0.2 mM iodoacetamide at  pH 6.8 
in 0.1 M Tris-acetate buffer containing 2 mM CaC12. 
Extract was treated for 4 h at  4 “C with affinity purified anti- 
transglutaminase antibody (20 pg/ml) and goat anti-rabbit IgG 
(which, itself, did not inhibit transglutaminase activity). The immune 
complexes were  removed by centrifugation before assay. 
was inhibited by iodoacetamide under conditions known to 
favor this reaction (Folk and Cole, 1966). Enzymatic activity 
could be completely removed from the cell extract by immu- 
noprecipitation with the monospecific anti-transglutaminase 
antibody. 
Increase in Transglutaminase Activity in  Stimulated  Mast 
Cells-Elevated levels of transglutaminase activity were ob- 
served in cell lysates prepared from mast cells previously 
activated to release histamine by either immunologic or non- 
immunologic stimuli (Fig. 2). Unsensitized cells  showed a 2- 
to 7-fold increase in enzyme activity upon stimulation with 
ionophore A23187 or ionophore Br-x537A (Fig. 2 A ) .  ConA, 
which is capable of inducing histamine release from PT18 
mast cells (Barrett  et al., 1984) did not significantly increase 
transglutaminase activity. Cells passively sensitized with anti- 
ovalbumin IgE and challenged with ovalbumin showed the 
highest increase in transglutaminase activity (Fig.  2B). The 
concentration of immunologic and nonimmunologic secreta- 
gogues used were those reported to induce maximum hista- 
mine release (Barrett  et al., 1984), and enzyme activity was 
assayed 10 min after  stimulation, when the histamine release 
was complete (Barrett et al., 1984). 
Labeled y-Glutamylhistamine in Proteins from Mast Cells 
Metabolically  Labeled with PHJHistidine-The methodology 
employed here for identification of protein-bound y-gluta- 
mylhistamine is similar to  that which was used to identify y- 
glutamylpolyamine derivatives in  proteins (Folk et al., 1980). 
Briefly, the cellular protein  fraction is subjected to exhaustive 
proteolytic digestion, and the covalently bound amine, re- 
leased as a stable y-glutamyl derivative, is separated chro- 
matographically. For this approach to be valid it is essential 
that y-glutamylhistamine be stable to conditions used for 
proteolytic digestion of the protein  fraction, that  the digestion 
conditions yield the expected derivative from the protein- 
amine conjugate, and  that formation of y-glutamylhistamine 
does not occur as  an artifact of the digestion procedure. As 
with the y-glutamylpolyamines, synthetic y-glutamylhista- 
mine was found stable to digestion, and essentially quantita- 
tive release of radiolabeled y-glutamylhistamine was  observed 
upon digestion of a [3H]histamine-casein conjugate prepared 
as outlined under “Experimental Procedures.” When the 
digestion protocol was carried out using unmodified casein or 
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FIG. 2. Transglutaminase activ- 
ity  in cell  lysates of mouse mast cells 
before and after histamine release. 
Transglutaminase levels are given as 
means & S.E. of five determinations. The 
data for per  cent of total cell histamine 
released are those obtained from sepa- 
rate experiments. A, unsensitized cells; 
B, IgE-sensitized cells. Ag is aggregated 
ovalbumin, the antigen in  this system. 





extracts from mast cells grown without radiolabel under the 
same conditions and to which labeled histamine was added at 
the beginning of the digestion, no y-glutamylhistamine was 
found. Thus,  the occurrence of y-glutamylhistamine  in  pro- 
tein digests is strong evidence for covalent conjugation of 
histamine  through y-glutamyl linkage in  these proteins. 
Our first approach in an effort to obtain evidence for 
covalent incorporation of histamine  into cellular protein was 
to label histamine metabolically through growth of mouse 
mast cells in  the presence of [3H]histidine. This, of course, 
also results  in radiolabeling of most, if not all, of the cellular 
proteins with [3H]histidine. Because y-glutamylhistamine is 
not  separated from histidine  in  our ion exchange chromato- 
graphic system (Fig. 3A), direct identification of y-gluta- 
mylhistamine by this procedure was impossible. As an indirect 
approach, a  portion of the digest from labeled cells that had 
been stimulated immunologically was treated with the enzyme 
y-glutamylamine cyclotransferase in order to release free 
histamine from the y-glutamyl derivative. This enzyme has 
been shown to catalyze production of 5-oxoproline and free 
amines from y-glutamylamines (Fink et al., 1980). A small 
increase in  the amount of free histamine could be detected in 
this way (Fig. 3B). However,  owing to  the fact that  there was 
always some unconjugated labeled histamine nonspecifically 
bound to  the trichloroacetic acid-precipitated proteins and 
that  this histamine was released during digestion, this ap- 
proach provided only a suggestion of the presence of the  y- 
glutamyl derivative. Circumstantial evidence was obtained by 
collecting fractions corresponding to  the y-glutamylhistamine 
region of the chromatogram, treating  them directly with y- 
glutamylamine cyclotransferase, and rechromatographing 
(Fig. 3C). In  this case counts  eluted at  the position of hista- 
mine were found to be in good agreement with the increased 
number of counts observed in the previous case, strongly 
suggesting the presence of y-glutamylhistamine in  the digest. 
Positive identification was made by the use of a reverse 
phase high performance liquid chromatography system in 
which a  separation of histidine  and  y-glutamylhistamine was 
accomplished (Fig. 4). Fig. 5A shows the separation obtained 
with the digest of cell proteins  prepared from metabolically 
labeled, immunologically stimulated  mast cells. Here, a dis- 
tinct peak of radioactivity is observed at the position of y- 
glutamylhistamine. This  material was collected and examined 
by chromatography in  the ion exchange system described in 
Fig. 3. The radioactivity was found to elute exclusively at  the 
h 















position of synthetic y-glutamylhistamine (Fig. 5B). Treat- 
ment with y-glutamylamine cyclotransferase provided the 
final proof of its  identity (Fig. 5C). 
y-Glutamylhistamine in  Proteins from Mast Cells Activated 
in the Presence of f'HJHistamine-Because of the abundance 
of radiolabeled histidine in proteins of cells metabolically 
labeled with [3H]histidine, it was not possible to identify the 
protein or proteins that contain radioactivity in the form of 
histamine. In an attempt to overcome this problem [3H] 
histamine (2 pCi/ml) was supplied externally to cells imme- 
diately prior to stimulation. Ten minutes  after the addition 
of secretagogues, a  portion of the cells was precipitated by the 
addition of trichloroacetic acid and digested proteolytically as 
described. Another portion of these cells was collected by 
centrifugation, resuspended in  TBS,  denatured,  and analyzed 
by SDS-gel electrophoresis. The digest prepared from immu- 
nologically stimulated cells contained  a detectable amount of 
radioactivity that chromatographed at  the position of y-glu- 
tamylhistamine as shown in Fig. 6A. In addition to this 
component and histamine, small amounts of other radioactive 
materials were  observed. These may result from oxidation of 
histamine by amine oxidases present  in mast cells (Beaven, 
1982). Examination of SDS-gels prepared from samples of 
undigested cell protein showed a radiolabeled component(s) 
that did not enter the stacking gel (Fig. 6B). 
Level of y-Glutamylhistamine in Mast Cells-Table  I1  shows 
the  content of y-glutamylhistamine in cells before and  after 
stimulation. Included are  results obtained with cells metabol- 
ically labeled with [3H]histidine and  those labeled by treat- 
ment with radiolabeled histamine. In each case data were 
obtained for both immunologic and nonimmunologic stimu- 
lation and in each case the greatest incorporation was ob- 
served after immunologic stimulation. 
Association of Both Transglutaminase and y-Glutamylhis- 
tamine with the Cellular Protein Fraction following  Cell Stim- 
ulation-Table I11 summarizes the results of an experiment 
in which transglutaminase activity and  the level of y-gluta- 
mylhistamine were measured both in the cells and in the 
noncellular fraction following cell stimulation. Clearly, the 
majority of both enzyme activity and y-glutamylhistamine 
remain associated with the cells. It was also observed that 
when unlysed cells were assayed for transglutaminase activity, 
a significant proportion of total enzyme activity was ex- 
pressed, but only after cell stimulation. 
y-Glutamylhistamine was not detected in the undigested 
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FIG. 3. Ion exchange  chromatographic  properties of histi- 
dine, y-glutamylhistamine, and histamine. Chromatography was 
carried out according to a published procedure (Folk et al., 1980) 
except for omission of the first buffer of the five-buffer system. 
Fractions were collected for 1.5 min. A, distribution of radioactivity 
from samples of 3H-labeled histidine (A) and of 3H-labeled y-gluta- 
mylhistamine, before (0) and  after (0) its incubation with the enzyme 
y-glutamylamine cyclotransferase. The arrow indicates the position 
of histamine. B, distribution of radioactivity in  a digest of the protein 
fraction from mast cells, before (0) and  after (0) its  incubation with 
y-glutamylamine cyclotransferase. C, distribution of radioactivity 
after incubation of fraction 17 from B (0) with y-glutamylamine 
cyclotransferase. The cells were metabolically labeled with [3H]his- 
tidine and release of histamine was triggered immunologically. In B,  
incubation with y-glutamylamine cyclotransferase was carried out for 
2 h at  pH 7.0 in 0.33 M sodium phosphate buffer using the digest 
from approximately 1.2 mg  of cell protein and 3.0 units of enzyme in 
1 ml. In C, treatment with enzyme was under the same conditions of 
pH and enzyme. The  pH of fraction 17 was adjusted to  pH 7.0 before 
addition of buffer and enzyme. 
trichloroacetic acid-soluble fraction of either the cellular pel- 
let or the released material in these experiments, suggesting 
that there is no mechanism for formation of free y-gluta- 
mylhistamine in  these cells. 
DISCUSSION 
The main purpose of this study was to provide evidence for 
transglutaminase-catalyzed production of covalent protein- 
histamine conjugates in cells. Indeed, the results clearly show 
that, when PT18 mouse mast cells, in which the transgluta- 
minase gene is expressed, are triggered to release histamine, 
there  is an increase in transglutaminase activity accompanied 
by an increased formation of y-glutamylhistamine in cellular 
protein (Fig. 2  and  Table 11). Although this is not  direct proof 
that histamine incorporation into  protein  is  a cellular function 
for transglutaminase(s), serious consideration must be  given 
to  this possibility. 
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FIG. 4. High performance liquid chromatographic separa- 
tion of histidine  and y-glutamylhistamine. Chromatography was 
conducted with a  Waters  instrument. A 3.9 mm X 30 cm microbon- 
dapak CIS column was used with 10 mM NH4HC03 as  the mobile 
phase. Elution was at 2.5 ml/min and fractions were collected for 0.5 
min. For convenience, radiolabeled forms of the histidine and y- 
glutamylhistamine were  employed. 
Certainly, the evidence for y-glutamylhistamine production 
is convincing. Identification was made in proteolytic digests 
by chromatography in  both ion exchange and reverse phase 
high performance systems (Figs. 3  and 5, respectively) and by 
release of histamine  through the catalytic action of y-gluta- 
mylamine cyclotransferase (Fig. 5), an enzyme specific for 
disassembly of y-glutamylamines (Fink et al., 1980). 
The facts (i) that before stimulation, mast cells, which 
possess very high levels of histamine, are found to contain 
only small amounts of y-glutamylhistamine and (ii) that upon 
stimulation, these cells lose a large percentage of their  hista- 
mine and at this  time display increases in  both  transgluta- 
minase activity and in y-glutamylhistamine are consistent 
with a suggestion that stimulation to release histamine or its 
release per se provides a specific biochemical signal for catal 
lytic incorporation of histamine into cellular protein. That 
this catalytic step is not simply the consequence of a signaled 
increase in  transglutaminase activity seems evident because 
the mast cells contain significant amounts of this enzyme 
activity before stimulation (Fig. 1 and  Table 111). 
The recent  reports of a highly reactive intramolecular y- 
glutamyl thiol ester in certain proteins, albeit extracellular 
ones, and of its reaction with primary  amines to yield protein- 
bound y-glutamylamines (Tack et al., 1980; Van Leuven, 
1984) demand consideration of this  type of noncatalytic re- 
action  as an alternative mechanism for attachment of hista- 
mine to cellular protein. It is clear, therefore, that our findings 
of enhanced  transglutaminase activity and production of pro- 
tein-bound  histamine do not provide the evidence sought to 
define an important  intracellular role for transglutaminase(s). 
They  are, however, unique in showing concomitancy of these 
two cellular events. There have been a number of reports of 
increases in cellular transglutaminase activity following stim- 
ulation of immunocompetent cells, e.g. human peripheral 
blood lymphocytes (Novogrodsky et al., 1978), antigen-spe- 
cific B lymphocytes (Julian et al., 1983), and monocytes and 
macrophages (Fesus et al., 1981, Leu et al., 1982) and several 
papers  present data on the occurrence of y-glutamylamines 
in cellular proteins (Folk et aL, 1980; Fan et aL, 1983; Cariello 
et aL, 1984). To our knowledge this  is  the first  report in which 
the enzyme and its possible product have been shown to 
increase concurrently upon stimulation of cells. It is signifi- 
cant  in  this connection that in 1963 Ginsburg et al. reported 
a definite increase in both transglutaminase activity and 
protein-bound histamine in the livers of endotoxin-treated 
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FIG. 5. Identification of y-glutamylhistamine  in  the  digest of a protein  fraction  from PTlS cells that 
had  been  stimulated  immunologically. Prior  to high performance liquid chromatography, a 2.0-ml portion of 
the digest (approximately 3.2 mg  of protein) was applied to a 0.8 X 5-cm column of Bio-Rex 70 resin (NH4+ form 
adjusted to  pH 4.7 with acetic acid). Neutral and acidic components were washed from the resin with water, and 
y-glutamylhistamine was eluted with 1.0 N NH40H.  The eluate was evaporated under  a  stream of nitrogen and 
dissolved in water for analysis. A, high performance liquid chromatographic distribution of radioactivity from the 
digest. The chromatographic conditions were those described in Fig. 4. B, ion exchange chromatography of the y- 
glutamylhistamine fraction  separated by high pressure liquid chromatography in A. The conditions for chromatog- 
raphy were as outlined in Fig. 3. C, ion exchange chromatography of the y-glutamylhistamine fraction separated 




mice that were administered high levels of histamine. Even 
at  this early date  the question was raised whether  there  is a 
causal connection between the increase in enzyme and  the 
increased histamine incorporation (Waelsch, 1962). A  quota- 
tion from Waelsch's paper is relevant to our present finding: 
". . . does transglutaminase  participate  in the histamine fixa- 
tion in vivo? A direct proof is difficult, and  the isolation of 
the corresponding y-glutamylhistamine would provide only 
further  circumstantial evidence." 
The level of protein-bound y-glutamylhistamine found here 
in metabolically labeled mast cells after  stimulation (350-500 
pmol/mg protein,  Table 11) may be compared with that re- 
ported by Ginsburg et al. for histamine covalently attached to 
liver protein of endotoxin-treated mice after  their injection 
with histamine (3-5 pmol/mg protein) assuming that this 
latter value was, indeed, a measure of histamine conjugated 
in y-glutamyl linkage. The considerably higher level found in 
the stimulated  mast cells is perhaps  not  surprising since these 
cells are rich in  the amine. In vivo, histamine may be incor- 
porated  into  protein only within cells and/or only in  certain 
cells may incorporation occur. In this respect, fibroblasts 
(Chinese hamster ovary cells), which contain  a high level of 
transglutaminase (Davies et al., 19% Fesus et aL, 1985),  when 
cultured  in  a medium containing radiolabeled histamine,  are 
found to internalize the amine, but to produce no detectable 
protein-bound y-glutamylhistamine.' It is perhaps significant 
L. Fesus, unpublished observation. 
in this regard that production of the covalently bound hista- 
mine derivative is measurable in these cells following an 
increase in transglutaminase activity (particularly in the cell 
membrane fraction; Fesus et al., 1985) induced by the tumor 
promoter phorbol ester. 
After mast cell activation a significant portion of the  trans- 
glutaminase activity can be detected without lysis of the cells 
(Table 111). Because little enzyme activity is found in the 
noncellular fraction following activation, there  is reason to 
believe that a significant amount of enzyme becomes oriented 
on the outer surface of these cells. There are reports of 
transglutaminase activity on the surface of human macro- 
phages (Murtaugh et al., 1983b) and  in association with mi- 
crovesicles shed from the surface of tumor cells (Fesus et al., 
1985). It is possible that in vivo mast cells supply both enzyme 
and  amine  substrate  in the proper orientation for extracellular 
production of protein bound y-glutamylhistamine. 
Free y-glutamylhistamine occurs as a major product of 
histamine metabolism in the ganglia of marine mollusks 
(Weinreich, 1978) and free y-glutamylhistamine is found in 
rat brain  after  intraventricular injection of histamine  (Koni- 
shi  and Kakimoto, 1976). The mechanism of its formation is 
not understood. The absence of free y-glutamylhistamine in 
mast cells either before or after  stimulation is evidence that 
these cells provide no means for conjugation of histamine  in 
this  manner. 
Among the several theories regarding the physiological  role 
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FIG. 6. Examination of the protein fraction of mast cells 
triggered to release histamine in the presence of [3H]hista- 
mine. A, ion exchange  chromatography was conducted as outlined in 
Fig. 3. The arrows designate the positions of y-glutamylhistamine 
and histamine, respectively. The upper chromatogram is that from a 
digest of the cells. The radioactivity in  the position of histamine is 
presumed to be due to noncovalently  bound  histamine released from 
cellular proteins during digestion. The lower chromatogram is that 
obtained  upon treatment of the y-glutamylhistamine  fraction of the 
first chromatogram  with the enzyme y-glutamylamine  cyclotransfer- 
ase  (condition of Fig. 3). B, SDS-gel  electrophoresis and autoradiog- 
raphy were performed as described in Fig. 1. In lane 1 are shown the 
positions of protein standards as determined in Fig. 1 (molecular 
weights are given in kilodaltons; lane 2, 200 pg  of protein from 
unstimulated cells that were incubated  with  [3H]histamine  for  10 min 
before preparation for electrophoresis; lune 3, 100 pg  of protein from 
cells stimulated immunologically; lane 4, 100 pg  of protein from cells 
stimulated with the calcium ionophore A-23187. 
TABLE I1 
Content of y-glutam.ylhistamine in PT18 mast cell protein 
y-Glutamylhistaminea 
Stimuli In protein of cells In protein of cells labeled  metaboli- incubated with 
[3H] histamine cally  with [3H] histidine 
pmollmg protein 
None 16  Undetectable 
Antigen 589 121 
IonoDhore A23187 334  34 
The  quantities of y-glutamylhistamine were calculated based on 
the specific radioactivity of intracellular  histamine. Specific radioac- 
tivity in the trichloroacetic  acid supernatant from washed cells was 
determined from fluorometric  measurements of histamine  (Shore et 
al., 1959) and measurements of histamine radioactivity following 
separation by ion exchange  chromatography.  Full recovery of cova- 
lently  bound histamine  as y-glutamylhistamine was indicated by the 
facts  that essentially  all of the radioactivity in digests was accounted 
for after chromatography and  that,  other  than histidine,  histamine, 
and y-glutamylhistamine,  only  minor  radioactive  materials were ob- 
served in chromatograms. 
TABLE 111 
Association of transglutaminase activity and y-glutamylhistamine 
with cells 
Cell stimulationm Transglutaminase activityb y-Glutamylhistamine‘ 
% associated with cells 
Nonstimulated cells 87 (2.0) 92 
Immunologic stimuli 91 (27) 86 
Ionophore A23187 83 (23) 94 
a Cells were incubated  with or without  stimuli  under the conditions 
outlined under “Experimental Procedures.” After 10 min, the cells 
and  the noncellular  fraction were separated by centrifugation (5 min 
at  2000 X g). 
bTransglutaminase activity was measured in an experiment in 
which nonradiolabeled cells were used. Measurements were made 
before and  after lysis of cells. The values given in parentheses are 
those for the per cent of the total enzymatic activity found with 
unlysed cells. 
‘The  amounts of y-glutamylhistamine were determined as out- 
lined in Table I1 using cells metabolically labeled with [3H]histidine. 
of cellular transglutaminase is its possible involvement in 
receptor-mediated endocytosis  (Davies et al., 1980). However, 
the  recent  finding  that  receptor-mediated endocytosis  occurs 
normally  in  transformed  fibroblasts  that have undetectable 
amounts of transglutaminase (Davies et al., 1984) does not 
support  this hypothesis. In  mast cells detailed studies of the 
receptor complex proteins (Metzger et al., 1983) have not 
suggested a posttranslational modification of a type catalyzed 
by the  transglutaminases. Arguments  associating transgluta- 
minase activation to Fc receptor stimulation (Julian et al., 
1983; Fesus et al., 1984) are  too  preliminary  to  support a  role 
for transglutaminase activation in the process of receptor- 
mediated  stimulation of histamine release. I t  is possible, how- 
ever, that  the  covalent i corporation of histamine  into cellular 
proteins  is a mechanism limiting the release reaction.  Proof 
for such  an  assumption requires not only establishment of the 
role of transglutaminase  in  histamine incorporation but also 
the isolation of the  protein(s)  that  contains  the modified y- 
glutamyl  residues and  the coupling of its  function to critical 
steps  in  the biochemical cascade  leading to or limiting  hista- 
mine release. 
In  order  to  detect a  cellular protein  to which histamine  is 
covalently attached  during  mast cell activation,  it was  neces- 
sary for us  to supply labeled histamine directly to  the cells 
during  activation by supplementing  their medium with  this 
amine. This was the case, because only after addition of 
stimulant was a significant amount of labeled histamine 
transported  into  the cells. Lower contents of protein-bound 
y-glutamylhistamine were estimated  in  these cells on  the basis 
of histamine specific radioactivity than in those in which 
histamine was metabolically labeled with  histidine  (Table 11), 
possibly as a result of a  relatively slow rate of entry of labeled 
histamine  into  the cells even after cell activation.  Because of 
the possible differential in incorporation of histamine and 
entry of labeled amine,  the  present  finding of a histamine- 
containing high  molecular weight protein may reflect only the 
latter  stage of the overall reaction. I t  is  quite possible that 
this high  molecular weight protein is produced by transglu- 
taminase action, if indeed enzyme-catalyzed cross-linking 
through e-(y-glutamy1)lysine bonds occurs during  histamine 
release. In  any case, both  transglutaminase  and  the  protein(s) 
that  contain  the  y-glutamylhistamine  remain  within  the cells 
suggesting that  their roles, whatever they may be, are essen- 
tial. 
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